ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...
Dr Clémence Granier (AP-HP) will give a seminar on immunosenescence, infection and cancer, on 30 June at 14.00, at the IRS-UN
New scientific publication from INCIT Team 3: Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
New scientific publication from INCIT team 2: Response to immunotherapy in melanoma could be predicted by sun exposure traces on the skin.
Can't find what you want?